Such mutations would account for a small proportion of cases only but the increased risk of prostate cancer in male BRCA1 and BRCA2 mutation carriers indicates some commonality in histogenetic pathways in breast and prostate carcinomas. Here, BRCA2 is linked to prostate cancer.